A review of the bidirectional relationship between psychiatric disorders and diabetes mellitus

References

1. ↵
   1. Almutairi AF

   (2015) Mental illness in Saudi Arabia: an overview. Psychol Res Behav Manag 8, 47–49.
2. ↵
   1. Becker S,
   2. Al Zaid K,
   3. Al Faris E

   (2002) Screening for somatization and depression in Saudi Arabia: a validation study of the PHQ in primary care. Int J Psychiatry Med 32, 271–283.
3. ↵
   1. International Diabetes Federation

   (2011) Diabetes Atlas (IDF Publications;Brussels (Belgium)), 5th ed, 7–13, The Global Burden of Diabetes, Available from: http://www.idf.org/diabetesatlas/news/fifth-edition-release.
4. ↵
   1. Al-Sughayr AM,
   2. Ferwana MS

   (2012) Prevalence of mental disorders among high school students in National Guard Housing, Riyadh, Saudi Arabia. J Family Community Med 19, 47–51.
5. ↵
   1. Al-Geblan KS

   (2007) Depression, anxiety and stress among Saudi adolescent school boys. J R Soc Promot Health 127, 33–37.
6. ↵
   1. International Diabetes Federation Report 2009

   , https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/13-diabetes-atlas-seventh-edition.html.
7. ↵
   1. Alqurashi KA,
   2. Aljabri KS,
   3. Bokhari SA

   (2011) Prevalence of diabetes mellitus in a Saudi community. Ann Saudi Med 31, 19–23.
8. ↵
   1. Van Steenbergen-Weijenburg KM,
   2. van Puffelen AL,
   3. Horn EK,
   4. Nuyen J,
   5. van Dam PS,
   6. van Benthem TB,
   7. et al.

   (2011) More co-morbid depression in patients with Type 2 diabetes with multiple complications. An observational study at a specialized outpatient clinic. Diabet Med 28, 86–89.
9. ↵
   1. Bădescu SV,
   2. Tătaru C,
   3. Kobylinska L,
   4. Georgescu EL,
   5. Zahiu DM,
   6. Zăgrean AM,
   7. et al.

   (2016) The association between Diabetes mellitus and Depression. J Med Life 9, 120–125.
10. ↵
    1. Anderson RJ,
    2. Freedland KE,
    3. Clouse RE,
    4. Lustman PJ

    (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24, 1069–1078.
11. ↵
    1. Grigsby AB,
    2. Anderson RJ,
    3. Freedland KE,
    4. Clouse RE,
    5. Lustman PJ

    (2002) Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res 53, 1053–1060.
12. ↵
    1. Rajkumar AP,
    2. Horsdal HT,
    3. Wimberley T,
    4. Cohen D,
    5. Mors O,
    6. Børglum AD,
    7. et al.

    (2017) Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People with Schizophrenia: A Danish Population-Based Cohort Study. Am J Psychiatry 174, 686–694.
13. ↵
    1. Llorente MD,
    2. Urrutia V

    (2006) Diabetes, Psychiatric Disorders, and the metabolic effects of antipsychotic medications. Clin Diabetes 24, 18–24.
14. ↵
    1. Al-Qadhi W,
    2. ur Rahman S,
    3. Ferwana MS,
    4. Abdulmajeed IA

    (2014) Adult depression screening in Saudi primary care: prevalence, instrument and cost. BMC Psychiatry 14, 190.
15. ↵
    1. AlKhathami AD,
    2. Alamin MA,
    3. Alqahtani AM,
    4. Alsaeed WY,
    5. AlKhathami MA,
    6. Al-Dhafeeri AH

    (2017) Depression and anxiety among hypertensive and diabetic primary health care patients: Could patients'perception of their diseases control be used as a screening tool? Saudi Med J 38, 621–628.
16. ↵
    1. Kocabasoglu N

    1. Breznoščáková D,
    2. Nagyova I

    (2013) Depression and Glucose Metabolism (Diabetes Mellitus). Mental and Behavioural Disorders and Diseases of the Nervous System. in Mood Disorders, ed Kocabasoglu N (InTechOpen, Rijeka (Croatia)).
17. ↵
    1. Golden SH,
    2. Lazo M,
    3. Carnethon M,
    4. Bertoni AG,
    5. Schreiner PJ,
    6. Diez Roux AV,
    7. et al.

    (2008) Examining a bidirectional association between depressive symptoms and diabetes. JAMA 299, 2751–2759.
18. ↵
    1. Gemeay EM,
    2. Moawed SA,
    3. Mansour EA,
    4. Ebrahiem NE,
    5. Moussa IM,
    6. Nadrah WO

    (2015) The association between diabetes and depression. Saudi med J 36, 1210–1215.
19. ↵
    1. Das R,
    2. Singh O,
    3. Thakurta RG,
    4. Khandakar MR,
    5. Ali SN,
    6. Mallick AK,
    7. et al.

    (2013) Prevalence of depression in patients with type II diabetes and its impact on quality of life. Indian J Psychol Med 35, 284–289.
20. ↵
    1. Mansour EA,
    2. Gemeay EM,
    3. Moussa IM

    (2013) Counseling and depression among diabetic patients. Saudi Med J 34, 295–301.
21. ↵
    1. Wani RA,
    2. Dar MA,
    3. Margoob MA,
    4. Rather YH,
    5. Haq I,
    6. Shah MS

    (2015) Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia, before and after antipsychotic treatment. J Neurosci Rural Pract 6, 17–22.
22. ↵
    1. Annamalai A,
    2. Tek C

    (2015) An Overview of Diabetes Management in Schizophrenia Patients: Office Based Strategies for Primary Care Practitioners and Endocrinologists. Int J Endocrinol 2015, 969182.
23. 1. Smith M,
    2. Hopkins D,
    3. Peveler RC,
    4. Holt RI,
    5. Woodward M,
    6. Ismail K

    (2008) First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 192, 406–411.
24. 1. Rouillon F,
    2. Sorbara F

    (2005) Schizophrenia and diabetes: epidemiological data. Eur Psychiatry 4, 345–348.
25. ↵
    1. Dixon L,
    2. Weiden P,
    3. Delahanty J,
    4. Goldberg R,
    5. Postrado L,
    6. Lucksted A,
    7. et al.

    (2000) Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 26, 903–912.
26. ↵
    1. Keefe RS

    (2007) Cognitive deficits in patients with schizophrenia: effects and treatment. J Clin Psychiatry 68, 8–13.
27. ↵
    1. Leifker FR,
    2. Bowie CR,
    3. Harvey PD

    (2009) Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms. Schizophr Res 115, 82–87.
28. ↵
    1. Han M,
    2. Huang XF,
    3. Chen DC,
    4. Xiu M,
    5. Kosten TR,
    6. Zhang XY

    (2013) Diabetes and cognitive deficits in chronic schizophrenia: a case-control study. PLoS One 8, e66299.
29. ↵
    1. Subramaniam M,
    2. Chong SA,
    3. Pek E

    (2003) Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia. Can J Psychiatry 48, 345–347.
30. ↵
    1. Balhara YP

    (2011) Diabetes and psychiatric disorders. Indian J Endocrinol Metab 15, 274–283.
31. ↵
    1. Kuzman MR,
    2. Medved V,
    3. Bozina N,
    4. Hotujac L,
    5. Sain I,
    6. Bilusic H

    (2008) The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients. Psychiatry Res 160, 308–315.
32. ↵
    1. Lambert BL,
    2. Cunningham FE,
    3. Miller DR,
    4. Dalack GW,
    5. Hur K

    (2006) Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia. Am J Epidemiol 164, 672–681.
33. ↵
    1. Liao TV,
    2. Phan SV

    (2014) Acute hyperglycemia associated with short-term use of atypical antipsychotic medications. Drugs 74, 183–194.
34. 1. Mittal D,
    2. Li C,
    3. Viverito K,
    4. Williams JS,
    5. Landes RD,
    6. Thapa PB,
    7. et al.

    (2014) Monitoring for metabolic side effects among outpatients with dementia receiving antipsychotics. Psychiatr Serv 65, 1147–1153.
35. ↵
    1. Argo T,
    2. Carnahan R,
    3. Barnett M,
    4. Holman TL,
    5. Perry PJ

    (2011) Diabetes prevalence estimates in schizophrenia and risk factor assessment. Ann Clin Psychiatry 23, 117–124.
36. ↵
    1. Lindenmayer JP,
    2. Czobor P,
    3. Volavka J,
    4. Citrome L,
    5. Sheitman B,
    6. McEvoy JP,
    7. et al.

    (2003) Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. Am J Psychiatry 160, 290–296.
37. ↵
    1. Goudie AJ,
    2. Halford JC,
    3. Dovey TM,
    4. Cooper GD,
    5. Neill JC

    (2003) H(1)-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 28, 2209.
38. ↵
    1. Newcomer JW

    (2005) Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 19, 1–93.
39. ↵
    1. Prochaska JJ,
    2. Das S,
    3. Young-Wolff KC

    (2017) Smoking, mental illness, and public health. Annu Rev Public Health 38, 165–185.
40. ↵
    1. Sciberras E,
    2. Mulraney M,
    3. Silva D,
    4. Coghill D

    (2017) Prenatal risk factors and the etiology of ADHD-review of existing evidence. Curr Psychiatry Rep 19, 1.
41. ↵
    1. Persson PG,
    2. Carlsson S,
    3. Svanström L,
    4. Ostenson CG,
    5. Efendic S,
    6. Grill V

    (2000) Cigarette smoking, oral moist snuff use and glucose intolerance. J Intern Med 248, 103–110.
42. ↵
    1. Shaw NJ,
    2. Mc Clur RJ,
    3. Kerr S,
    4. Lawton K,
    5. Smith CS

    (1993) Smoking in diabetic teenagers. Diabet Med 10, 275–277.
43. ↵
    1. Chang SA

    (2012) Smoking and diabetes. Diabetes Metab J 36, 399–403.